Literature DB >> 8955092

Contribution of a nuclear factor 1 binding site to the glucocorticoid regulation of the cytosolic aspartate aminotransferase gene promoter.

M Garlatti1, M Aggerbeck, J Bouguet, R Barouki.   

Abstract

Two regions of the cAspAT gene promoter mediate the glucocorticoid regulation of this gene in the Fao hepatoma cell line. The proximal region was localized by deletion studies and stable transfections in the Fao cells to the sequence -553/-398. This region includes the glucocorticoid-responsive element (GRE) A sequence, which consists of two overlapping GREs and which can mediate the glucocorticoid regulation of a heterologous promoter. DNase I footprinting studies have shown that a site 80 base pairs upstream of the GRE A was protected by liver and brain nuclear extracts (site P8). The binding was displaced by an excess of an oligonucleotide containing a typical NF1 binding site and by NF1-specific antibodies. In electrophoretic mobility shift assay using the P8 oligonucleotide as a probe, several complexes were formed. Most complexes were common to liver and brain but were less abundant when testis extracts were used. At least one complex was specific to the liver. All complexes, with the exception of two, were competed for by the NF1 oligonucleotide. Furthermore, the sequence of the P8 site showed a 7/9-base pair homology with a typical NF1 site. A mutation of the P8 site, which prevents the binding of NF1-like proteins to it, considerably decreases the regulation of the cAspAT promoter fragment by glucocorticoids. Surprisingly, the basal activity of the mutant promoter was increased 2-fold. Thus, the regulation of the cAspAT gene promoter is mediated by a regulatory unit comprising the GRE A and a NF1 binding site.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8955092     DOI: 10.1074/jbc.271.51.32629

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  The genomic response of skeletal muscle to methylprednisolone using microarrays: tailoring data mining to the structure of the pharmacogenomic time series.

Authors:  Richard R Almon; Debra C DuBois; William H Piel; William J Jusko
Journal:  Pharmacogenomics       Date:  2004-07       Impact factor: 2.533

2.  An autoregulatory loop controlling CYP1A1 gene expression: role of H(2)O(2) and NFI.

Authors:  Y Morel; N Mermod; R Barouki
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

3.  Neuronal expression of the 5HT3 serotonin receptor gene requires nuclear factor 1 complexes.

Authors:  F K Bedford; D Julius; H A Ingraham
Journal:  J Neurosci       Date:  1998-08-15       Impact factor: 6.167

4.  Modeling Corticosteroid Pharmacogenomics and Proteomics in Rat Liver.

Authors:  Vivaswath S Ayyar; Siddharth Sukumaran; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  J Pharmacol Exp Ther       Date:  2018-08-07       Impact factor: 4.030

5.  Pharmacodynamic modeling of acute and chronic effects of methylprednisolone on hepatic urea cycle genes in rats.

Authors:  Anasuya Hazra; Debra C DuBois; Richard R Almon; Grayson H Snyder; William J Jusko
Journal:  Gene Regul Syst Bio       Date:  2008-02-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.